Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05877924
What this trial is testing

NBL-020 Injection in Subjects With Advanced Malignant Tumors.

Who this might be right for
Advanced Malignant Tumors
NovaRock Biotherapeutics, Ltd 200
Testing effectiveness (Phase 2)Study completedNCT02280317
What this trial is testing

Dose Finding Safety Study of VAL201 in Cancer Patients

Who this might be right for
Stage III Prostate CarcinomaStage IV Prostate Carcinoma
ValiRx Plc 12
Early research (Phase 1)Study completedNCT02159989
What this trial is testing

Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmFibrolamellar CarcinomaMetastatic Malignant Solid Neoplasm+5 more
National Cancer Institute (NCI) 83
Early research (Phase 1)Study completedNCT02526017
What this trial is testing

Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers

Who this might be right for
Advanced Solid TumorsHead and Neck CancerPancreatic Cancer+4 more
Five Prime Therapeutics, Inc. 313
Early research (Phase 1)UnknownNCT05829057
What this trial is testing

The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1

Who this might be right for
Esophagus CancerBladder CancerLiver Cancer+2 more
Zhejiang University 10
Early research (Phase 1)Active Not RecruitingNCT05068102
What this trial is testing

Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck (HNSCC)MelanomaNon-small Cell Lung Cancer (NSCLC)
Boehringer Ingelheim 14
Early research (Phase 1)Study completedNCT01012102
What this trial is testing

EMD 640 744 in Montanide ISA 51 VG Administered in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Merck KGaA, Darmstadt, Germany 104
Not applicableWithdrawnNCT03115528
What this trial is testing

Difference in the Estimation of Prognosis

Who this might be right for
Malignant Neoplasms of Independent (Primary) Multiple Sites
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Study completedNCT05809336
What this trial is testing

Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Beijing Friendship Hospital 172
Testing effectiveness (Phase 2)WithdrawnNCT00668499
What this trial is testing

VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma

Who this might be right for
Mesothelioma
University of Southern California
Testing effectiveness (Phase 2)Study completedNCT00060944
What this trial is testing

Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer

Who this might be right for
LiposarcomaLeiomyosarcoma
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 271
Early research (Phase 1)Study completedNCT01851265
What this trial is testing

D081AC00001 Food Interaction With Olaparib Capsule in Patients With Solid Tumours

Who this might be right for
Solid Tumours
AstraZeneca 32
Early research (Phase 1)WithdrawnNCT00997360
What this trial is testing

Study of PKI-179 Administered Orally to Subjects With Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Wyeth is now a wholly owned subsidiary of Pfizer
Testing effectiveness (Phase 2)Looking for participantsNCT04421820
What this trial is testing

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

Who this might be right for
Colorectal CancerPancreatic CancerGastric Cancers+1 more
Bold Therapeutics, Inc. 220
Testing effectiveness (Phase 2)Temporarily pausedNCT05089461
What this trial is testing

Evaluate the Cardiac Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Malignant Tumor

Who this might be right for
Advanced Malignant Tumor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 120
Testing effectiveness (Phase 2)Looking for participantsNCT07639450
What this trial is testing

N-3C01 Monotherapy and Combination With PD-(L)1 Inhibitors in Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Hefei Xinzhu Biological Technology Co., Ltd. 114
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06304818
What this trial is testing

Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB14 in Adult Patients With Advanced Malignant Solid Tumours.

Who this might be right for
Advanced Malignant Solid Tumours
Sinocelltech Ltd. 515
Early research (Phase 1)Looking for participantsNCT06958679
What this trial is testing

Evaluation of SYS6005 in Patients With Advanced Malignant Tumor

Who this might be right for
B-cell MalignanciesSolid Tumors
CSPC Megalith Biopharmaceutical Co.,Ltd. 132
Not applicableEnrolling By InvitationNCT07528079
What this trial is testing

Organoid-based Sensitivity-guided Chemotherapy for Advanced / Refractory Pediatric Tumors

Who this might be right for
Soft Tissue Sarcoma, Child
Shanghai Jiao Tong University School of Medicine 30
Early research (Phase 1)Study completedNCT02881190
What this trial is testing

Study of RC48-ADC Administered Intravenously to Subjects With HER2-Positive in Advanced Malignant Solid Tumors

Who this might be right for
Solid Tumors
RemeGen Co., Ltd. 57
Next Page